Literature DB >> 3657928

Colonization resistance of the digestive tract--mechanism and clinical consequences.

D van der Waaij1.   

Abstract

Potentially pathogenic bacteria and yeasts meet a number of resistance factors. These colonization resistance (CR) determining factors control the growth density of potentially pathogenic microorganisms in the various parts of the alimentary canal. The CR of the digestive tract is to be seen partially of host origin but to a greater extent due to direct and indirect activity of the (anaerobic) indigenous microflora. This implies that the CR mechanism is vulnerable to antibiotics which affect the indigenous flora during treatment. A decreased CR enhances colonization by microorganisms that are resistant to the antibiotic(s) used for therapy. Increased population densities of potentially pathogenic bacteria ("overgrowth") may correlate with invasion of the mucosal tissues often followed by translocation to remote lymphatic organs. Overgrowth also may correlate with development or acquisition of resistance to the antibiotic applied. By screening in experimental animals antibiotics have been selected which do not affect the CR. Such antimicrobial drugs have successfully been used to selectively eliminate potentially pathogenic bacteria and yeast in neutropenic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3657928     DOI: 10.1002/food.19870310551

Source DB:  PubMed          Journal:  Nahrung        ISSN: 0027-769X


  12 in total

1.  Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy.

Authors:  Katie L Mason; John R Erb Downward; Kelly D Mason; Nicole R Falkowski; Kathryn A Eaton; John Y Kao; Vincent B Young; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  Morphometrical parameters of gut microflora in human volunteers.

Authors:  B C Meijer; G J Kootstra; M H Wilkinson
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

3.  Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs.

Authors:  A E van den Bogaard; M Hazen; M Hoyer; P Oostenbach; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Alarmin HMGB1 is released in the small intestine of gnotobiotic piglets infected with enteric pathogens and its level in plasma reflects severity of sepsis.

Authors:  Alla Splichalova; Igor Splichal; Petra Chmelarova; Ilja Trebichavsky
Journal:  J Clin Immunol       Date:  2011-01-12       Impact factor: 8.317

5.  Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats.

Authors:  Hayrettin Ozturk; Halil Eken; Hulya Ozturk; Huseyin Buyukbayram
Journal:  Pediatr Surg Int       Date:  2006-08-01       Impact factor: 1.827

6.  Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis.

Authors:  Katie L Mason; John R Erb Downward; Nicole R Falkowski; Vincent B Young; John Y Kao; Gary B Huffnagle
Journal:  Infect Immun       Date:  2011-10-10       Impact factor: 3.441

7.  Bacterial translocation and gut microflora in obstructive jaundice.

Authors:  R W Parks; W D Clements; C Pope; M I Halliday; B J Rowlands; T Diamond
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

8.  Role of the gut in the pathophysiology of extrahepatic biliary obstruction.

Authors:  W D Clements; R Parks; P Erwin; M I Halliday; J Barr; B J Rowlands
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 9.  The emerging world of the fungal microbiome.

Authors:  Gary B Huffnagle; Mairi C Noverr
Journal:  Trends Microbiol       Date:  2013-05-17       Impact factor: 17.079

10.  Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans.

Authors:  John R Erb Downward; Nicole R Falkowski; Katie L Mason; Ryan Muraglia; Gary B Huffnagle
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.